Optiva Inc. (RKNEF)
USD 2.15
(0.0%)
USD 2.15
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 47.5 Million | 61.77 Million | 65.23 Million | 75.91 Million | 98.95 Million | 121.62 Million |
| Cost of Revenue | 16.89 Million | 17.19 Million | 14.87 Million | 19.6 Million | 37.12 Million | 50.71 Million |
| Gross Profit | 30.61 Million | 44.58 Million | 50.36 Million | 56.31 Million | 61.83 Million | 70.91 Million |
| Operating Expenses | 31.87 Million | 33.02 Million | 35.4 Million | 63.54 Million | 52.63 Million | 103.92 Million |
| Selling, General and Administrative Expenses | 17.4 Million | 15.31 Million | 16.17 Million | 12.26 Million | 23.97 Million | 15.74 Million |
| Research and Development Expenses | 13.75 Million | 12.06 Million | 10.5 Million | 25.53 Million | 28.66 Million | 61.51 Million |
| Other Expenses | 704.51 Thousand | 5.64 Million | 8.71 Million | 25.74 Million | - | - |
| Cost and Expenses | 48.76 Million | 50.22 Million | 50.27 Million | 83.15 Million | 89.75 Million | 154.63 Million |
| Operating Income | -1.25 Million | 11.55 Million | 30.52 Million | -7.23 Million | 9.19 Million | -84.78 Million |
| Interest Expense | 10.23 Million | 8.77 Million | 8.77 Million | 3.96 Million | 10.85 Million | - |
| Income Tax Expense | 1.96 Million | 2.17 Million | 3.51 Million | 6.27 Million | 9.52 Million | 5.44 Million |
| Earnings before Tax | -10.28 Million | 2.88 Million | 22.01 Million | -35.24 Million | -1.72 Million | -87.14 Million |
| Net Income | -12.25 Million | 709 Thousand | 18.5 Million | -41.52 Million | -11.25 Million | -92.59 Million |
| Earnings Per Share Basic | -1.98 | 0.11 | 3.09 | -7.81 | -2.13 | -17.69 |
| Earnings Per Share Diluted | -1.98 | 0.11 | 3.08 | -7.81 | -2.13 | -17.69 |
| Weighted Average Shares Outstanding | 6.17 Million | 6.17 Million | 5.92 Million | 5.31 Million | 5.28 Million | 5.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.17 Million | 6.17 Million | 5.94 Million | 5.31 Million | 5.28 Million | 5.23 Million |
| Gross Margin | 0.64 | 0.72 | 0.77 | 0.74 | 0.62 | 0.58 |
| EBIT Margin | -0.01 | 0.24 | 0.49 | -0.27 | 0.14 | -0.21 |
| Profit Margin | -0.26 | 0.01 | 0.28 | -0.55 | -0.11 | -0.76 |
| EBITDA | -239 Thousand | 13.84 Million | 33.07 Million | -20.15 Million | 14.03 Million | -27.61 Million |
| Earnings Before Tax Margin | -0.03 | 0.19 | 0.47 | -0.10 | 0.09 | -0.70 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 11.39 Million | 11.65 Million | 12.33 Million | 48.37 Million | 11.72 Million | 11.09 Million |
| Cost of Revenue | 5.17 Million | 5.04 Million | 4.47 Million | 18.23 Million | 4.54 Million | 3.89 Million |
| Gross Profit | 6.21 Million | 6.6 Million | 7.85 Million | 30.13 Million | 7.18 Million | 7.19 Million |
| Operating Expenses | 8.66 Million | 9.58 Million | 9.69 Million | 31.41 Million | 8.19 Million | 5.62 Million |
| Selling, General and Administrative Expenses | 4.97 Million | 5.56 Million | -1.72 Million | - | 4.44 Million | 2.75 Million |
| Research and Development Expenses | 3.68 Million | 4.01 Million | 3.77 Million | - | 3.74 Million | 2.87 Million |
| Other Expenses | -4.97 Million | - | - | 498 Thousand | 498 Thousand | - |
| Cost and Expenses | 13.84 Million | 14.63 Million | 179.83 Million | 49.65 Million | 12.73 Million | 9.52 Million |
| Operating Income | -2.45 Million | -2.98 Million | -167.5 Million | -1.28 Million | -1.01 Million | 1.57 Million |
| Interest Expense | 2.84 Million | 2.82 Million | 1.91 Million | 10.23 Million | 2.43 Million | 2.39 Million |
| Income Tax Expense | 342.92 Thousand | 237.93 Thousand | -128 Thousand | 2 Million | 1.07 Million | 455 Thousand |
| Earnings before Tax | -5.25 Million | -5.76 Million | -4.13 Million | -10.47 Million | -3.1 Million | -839 Thousand |
| Net Income | -5.59 Million | -6 Million | -4.11 Million | -12.47 Million | -4.17 Million | -1.29 Million |
| Earnings Per Share Basic | -0.90 | -0.97 | -0.67 | - | -0.68 | -0.21 |
| Earnings Per Share Diluted | -0.90 | -0.97 | -0.67 | - | -0.68 | -0.21 |
| Weighted Average Shares Outstanding | 6.21 Million | 6.18 Million | 6.16 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.21 Million | 6.18 Million | 6.18 Million | 6.17 Million | 6.17 Million | 6.17 Million |
| Gross Margin | 0.55 | 0.57 | 0.64 | 0.62 | 0.61 | 0.65 |
| EBIT Margin | -0.20 | -0.24 | 1.00 | - | -0.02 | 0.17 |
| Profit Margin | -0.49 | -0.52 | -0.33 | -0.26 | -0.36 | -0.12 |
| EBITDA | -2.3 Million | -2.8 Million | 12.33 Million | - | -277 Thousand | 1.83 Million |
| Earnings Before Tax Margin | -0.22 | -0.26 | -13.58 | -0.03 | -0.09 | 0.14 |
MMTIF
KREVF
2270
0II3
TORNTPHARM
KROS